Auckland faces worst flu hospitalisation week in decade amid respiratory illness surge

Zero to four year olds and people aged 65+ experienced the highest hospitalisation rates; babies and toddlers were most commonly admitted to ICU with respiratory illness.
The combination of those two things has tipped us into this very high level of respiratory illness
Dr Hannah Cooper explains why multiple viruses circulating simultaneously created unprecedented pressure on Auckland's health system.
Mark

Why does it matter that this is the worst week in a decade? Isn't flu always bad in winter?

Mimi

Because the health system has a breaking point. 177 people in one week isn't just a number—it's beds filled, staff exhausted, and people waiting 17 hours in emergency departments. That's the system under strain.

Mark

But you said the flu itself isn't worse than usual. So what's actually different?

Mimi

The timing and the company it's keeping. Normally by mid-August, some respiratory viruses have already peaked and retreated. This year, RSV and rhinovirus are still circulating heavily. Then Subclade K arrives on top of that. It's not one wave—it's multiple waves hitting at once.

Mark

Why is Subclade K spreading so easily if the vaccine matches it?

Mimi

Because most people haven't been vaccinated yet, or they were vaccinated before they encountered the virus. The vaccine works, but only if you've had it. The virus has evolved enough that your body doesn't recognise it from past infections. It's moving through an unprotected population.

Mark

Who's actually getting the sickest?

Mimi

Babies and toddlers are ending up in ICU most often. But the elderly are also hospitalised in large numbers. The very young and very old have weaker immune systems. They're the ones who can't fight it off at home.

Mark

Is this going to get worse?

Mimi

That's the question no one can answer yet. If the virus continues to spread at this rate, yes. But viruses also burn through populations and run out of people to infect. The hope is that we're near the peak.

  • Auckland's four major hospitals admitted 177 people with severe respiratory illness in a single week — a number not seen in ten years, up sharply from 125 the week before.
  • H3N2 Subclade K has mutated far enough from recent flu strains that most people carry no natural immunity to it, allowing it to move through the population with unusual speed and reach.
  • Calls to Healthline surpassed the combined volume recorded at the same point in 2023, 2024, and 2025, while some Central region emergency departments reported waits exceeding 17 hours.
  • Babies and toddlers are being admitted to intensive care at the highest rates of any age group, with children under five and adults over 65 accounting for the largest share of hospitalisations.
  • New Zealand's flu vaccine was updated before the season to match Subclade K and is performing well — but its protection only extends to those who chose to receive it.

Once a decade, a city's health system encounters a moment that reveals the fragility beneath ordinary life — and Auckland has arrived at such a moment. In the week of August 9 to 16, 177 people were admitted to hospital with severe respiratory illness, the highest toll since 2015, driven by an evolved influenza strain called H3N2 Subclade K that most immune systems have never learned to recognise. The virus did not arrive alone: RSV and rhinovirus circulate alongside it, compounding the pressure on hospitals already stretched thin. The very young and the very old bear the heaviest cost, as they so often do when illness moves through a community unchecked.

In the week of August 9 to 16, Auckland's hospitals admitted 177 people with severe acute respiratory illness — a threshold not crossed since 2015. The jump from 125 admissions the prior week was sharp enough to signal something the city's health system had not faced in a decade.

Dr Hannah Cooper, a public health physician working in health intelligence, was careful to frame the crisis correctly. The flu itself was not more dangerous than strains from previous years. What made this winter different was volume — a surge of influenza layered on top of RSV and rhinovirus that had not yet retreated, creating a compounding pressure on hospitals already running hard. Frontline workers described unprecedented busyness, and the data confirmed it.

The strain driving much of the surge was H3N2 Subclade K, a variant that had evolved far enough from recent flu viruses that most people carried no natural immunity to it. It had already caused a severe outbreak in Europe earlier in the year before arriving in the southern hemisphere. Calls to Healthline exceeded the combined volume recorded at the same point across the previous three years, and some Central region emergency departments reported waits of more than 17 hours.

Two groups bore the sharpest burden. Children aged zero to four accounted for the largest share of hospitalisations, followed by people aged 65 and older. Babies and toddlers were the most common age group admitted to intensive care with respiratory illness in 2026.

There was one clear piece of good news: New Zealand's flu vaccine had been updated before the season to match Subclade K, and laboratory testing confirmed the circulating strains aligned well with its protection. Europe's experience also suggested the strain did not cause more severe disease in those who contracted it — only more of it. The vaccine was fit for purpose, though only for those who had received it. As August continued, the question was whether the surge had peaked or had further to climb.

In the week of August 9 to 16, Auckland's four major hospitals admitted 177 people with severe acute respiratory illness—a threshold not crossed since 2015. The number represented a sharp climb from the 125 patients admitted the week prior, and it signalled something the city's health system had not faced in a decade: a genuine crisis of respiratory disease pressing against hospital capacity.

Dr Hannah Cooper, a public health physician working in health intelligence, was careful to distinguish between severity and volume. The flu circulating this winter was not inherently worse than strains from previous years, she explained. What made it different was the sheer quantity of it, layered atop a background of other respiratory viruses—RSV, rhinovirus—that had not yet retreated as winter deepened. The combination created a perfect storm. Last Thursday had shown a spike in activity, but it remained within the normal range for a seasonal peak. By this week, the pressure had intensified further. Frontline health workers across the city were reporting unprecedented busyness, and the data confirmed it.

The surveillance system tracking these hospitalisations relies on a specific definition: people presenting to Auckland hospitals with fever and flu-like symptoms. It is a useful snapshot, Cooper noted, but an incomplete one. Some people infected with flu, RSV, or Covid never develop fever, and those cases fall outside the official count. The true number of people circulating through the community with respiratory illness was almost certainly higher than 177.

The culprit driving much of the surge was a particular variant of influenza A known as H3N2 Subclade K. This strain had earned its own designation because it had evolved significantly from recent H3N2 viruses. The more a flu virus mutates, the less the human immune system recognises it from previous infections. Most people in Auckland had no natural immunity to Subclade K. It had already caused a severe outbreak in Europe earlier in the year, and now it was running through the southern hemisphere population with little resistance.

Calls to Healthline, the national health advice line, surged alongside hospitalisations. The volume exceeded what had been recorded at the same point in 2023, 2024, and 2025 combined. The Central region—which includes Palmerston North—bore particular pressure. Some emergency departments there reported patients waiting more than 17 hours to be seen.

Two age groups bore the heaviest burden. Children aged zero to four accounted for the largest share of hospitalisations, followed by people aged 65 and older. Babies and toddlers were the most common age group admitted to intensive care with respiratory illness in 2026. The vulnerability of the very young and the very old was stark and consistent.

There was one piece of good news embedded in the data. New Zealand's flu vaccine had been updated before the southern hemisphere season to match Subclade K, and laboratory testing showed the circulating strains aligned well with what the vaccine protected against. Europe's experience suggested that while Subclade K could drive large numbers of infections, it did not appear to cause more severe disease in those who contracted it. The vaccine, in other words, was fit for purpose—though only for those who had received it.

As August moved forward, the question facing Auckland's health system was whether the surge would continue to climb or begin to recede. The combination of multiple respiratory viruses, a novel strain with low population immunity, and vulnerable groups concentrated in hospitals meant the pressure would likely persist for weeks.

This week it really has increased further. It's a particularly severe week of winter illness, which I think really corroborates what's being reported from all the frontline health services about how busy they are.
— Dr Hannah Cooper, public health physician at PHF Science
The more that a flu virus evolves, the less our bodies are able to sort of remember it from previous flu seasons.
— Dr Hannah Cooper, on why Subclade K spreads so easily
Want the full story? Read the original at RNZ ↗
Contact Us FAQ